Remed Co.,Ltd. (KOSDAQ:302550)

Remed Statistics

Total Valuation

Remed has a market cap or net worth of KRW 100.01 billion. The enterprise value is 93.03 billion.

Market Cap	100.01B
Enterprise Value	93.03B

Important Dates

The next estimated earnings date is Tuesday, November 11, 2025.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Remed has 31.11 million shares outstanding. The number of shares has increased by 9.41% in one year.

Current Share Class	31.11M
Shares Outstanding	31.11M
Shares Change (YoY)	+9.41%
Shares Change (QoQ)	+0.34%
Owned by Insiders (%)	35.69%
Owned by Institutions (%)	2.05%
Float	20.00M

Valuation Ratios

The trailing PE ratio is 16.17.

PE Ratio	16.17
Forward PE	n/a
PS Ratio	4.09
PB Ratio	2.32
P/TBV Ratio	2.54
P/FCF Ratio	345.99
P/OCF Ratio	101.88
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 57.99, with an EV/FCF ratio of 321.85.

EV / Earnings	14.36
EV / Sales	3.80
EV / EBITDA	57.99
EV / EBIT	n/a
EV / FCF	321.85

Financial Position

The company has a current ratio of 3.27, with a Debt / Equity ratio of 0.10.

Current Ratio	3.27
Quick Ratio	2.14
Debt / Equity	0.10
Debt / EBITDA	2.71
Debt / FCF	15.05
Interest Coverage	0.25

Financial Efficiency

Return on equity (ROE) is 16.68% and return on invested capital (ROIC) is 0.35%.

Return on Equity (ROE)	16.68%
Return on Assets (ROA)	0.30%
Return on Invested Capital (ROIC)	0.35%
Return on Capital Employed (ROCE)	0.61%
Revenue Per Employee	275.04M
Profits Per Employee	72.77M
Employee Count	89
Asset Turnover	0.42
Inventory Turnover	1.55

Taxes

In the past 12 months, Remed has paid 454.86 million in taxes.

Income Tax	454.86M
Effective Tax Rate	6.49%

Stock Price Statistics

The stock price has decreased by -15.72% in the last 52 weeks. The beta is 0.77, so Remed's price volatility has been lower than the market average.

Beta (5Y)	0.77
52-Week Price Change	-15.72%
50-Day Moving Average	3,447.70
200-Day Moving Average	3,423.95
Relative Strength Index (RSI)	34.26
Average Volume (20 Days)	198,683

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Remed had revenue of KRW 24.48 billion and earned 6.48 billion in profits. Earnings per share was 198.86.

Revenue	24.48B
Gross Profit	14.12B
Operating Income	276.33M
Pretax Income	7.01B
Net Income	6.48B
EBITDA	1.60B
EBIT	276.33M
Earnings Per Share (EPS)	198.86

Balance Sheet

The company has 13.47 billion in cash and 4.35 billion in debt, giving a net cash position of 9.12 billion or 293.33 per share.

Cash & Cash Equivalents	13.47B
Total Debt	4.35B
Net Cash	9.12B
Net Cash Per Share	293.33
Equity (Book Value)	43.10B
Book Value Per Share	1,316.61
Working Capital	20.23B

Cash Flow

In the last 12 months, operating cash flow was 981.55 million and capital expenditures -692.51 million, giving a free cash flow of 289.04 million.

Operating Cash Flow	981.55M
Capital Expenditures	-692.51M
Free Cash Flow	289.04M
FCF Per Share	9.29

Margins

Gross margin is 57.69%, with operating and profit margins of 1.13% and 26.46%.

Gross Margin	57.69%
Operating Margin	1.13%
Pretax Margin	28.65%
Profit Margin	26.46%
EBITDA Margin	6.55%
EBIT Margin	1.13%
FCF Margin	1.18%

Dividends & Yields

Remed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.41%
Shareholder Yield	-9.41%
Earnings Yield	6.48%
FCF Yield	0.29%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on December 8, 2023. It was a forward split with a ratio of 5.

Last Split Date	Dec 8, 2023
Split Type	Forward
Split Ratio	5

Scores

Remed has an Altman Z-Score of 6.64 and a Piotroski F-Score of 7.

Altman Z-Score	6.64
Piotroski F-Score	7